Jason Mills

Stock Analyst at Canaccord Genuity

(3.90)
# 608
Out of 4,944 analysts
108
Total ratings
70%
Success rate
36.89%
Average return

Stocks Rated by Jason Mills

Penumbra
Jul 30, 2025
Maintains: Buy
Price Target: $340$350
Current: $248.55
Upside: +40.82%
TransMedics Group
Oct 29, 2024
Maintains: Buy
Price Target: $169$109
Current: $131.13
Upside: -16.88%
STAAR Surgical Company
Apr 26, 2022
Maintains: Buy
Price Target: $81$89
Current: $27.39
Upside: +224.94%
AngioDynamics
Jul 14, 2021
Maintains: Hold
Price Target: $24$28
Current: $8.84
Upside: +216.74%
iRhythm Technologies
Nov 6, 2020
Maintains: Buy
Price Target: $236$273
Current: $162.35
Upside: +68.16%
Merit Medical Systems
Oct 29, 2020
Maintains: Buy
Price Target: $51$55
Current: $84.76
Upside: -35.11%
Neuronetics
Oct 26, 2020
Maintains: Buy
Price Target: $4$8
Current: $3.86
Upside: +107.25%
LeMaitre Vascular
Jul 24, 2020
Maintains: Hold
Price Target: $28$30
Current: $94.38
Upside: -68.21%
Intuitive Surgical
Jul 22, 2020
Maintains: Buy
Price Target: $187$242
Current: $478.19
Upside: -49.46%
LivaNova
Apr 30, 2020
Maintains: Hold
Price Target: $66$50
Current: $50.64
Upside: -1.26%
Maintains: Buy
Price Target: $41$45
Current: $35.82
Upside: +25.63%
Maintains: Buy
Price Target: $85$62
Current: $12.57
Upside: +393.24%
Maintains: Buy
Price Target: $43$46
Current: $102.64
Upside: -55.18%
Upgrades: Buy
Price Target: n/a
Current: $61.87
Upside: -